Pulmonary Arterial Hypertension News
- Most Severe COVID Tied to Four Cardiometabolic Conditions
- Outcomes Have Improved for PAH in Connective Tissue Disease
- COVID-19 Burdens Follow Patients After Discharge
- CHEST 2020 Switching to Riociguat Effective for Some Patients With PAH
- Systemic Sclerosis Patients Share Their Needs in Treatment Trials
- CHEST 2020 Selexipag Has No Effect on Daily Activity in PAH Patients
- HFSA 2020 Levosimendan Hints at Benefit in Unusual Form of Heart Failure
- ESC 2020 New ESC Guidelines on Adult Congenital Heart Disease
- HM 2020 Heart Failure: Practice-Changing Developments for Hospitalists
- HM 2020 Accurately Diagnosing Narrow Complex Tachycardias on EKGs
- ATS 2020 Pulmonary Rehab Reduces COPD Readmissions
- PVR Reassessed as Predictor of Heart Failure
- ATS 2020 Treprostinil Improves Walk Distance in Pulmonary Hypertension
- ESC-HF 2020 Mortality Differs by LVEF Between Women and Men
- Can Nitric Oxide Prevent COVID-19 Infection or Progression?
- ATS 2020 Inhaled Nitric Oxide Explored for COVID-19 Oxygenation
- Obesity Drug a New Treatment Option for Dravet Syndrome?
- CHEST 2019 Combo Improves Blood Flow in Pulmonary Arterial Hypertension
- Gadolinium Exposure Risk Highest in Early Pregnancy
- Alert EU Panel Backs Closer Sartan Monitoring, Generic PAH Drug